Frequency of pulmonary hypertension in chronic kidney disease patients (stages 3, 4, 5) at a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20242918Keywords:
Cardiovascular disease, Chronic kidney disease, Haemodialysis, Kidney damage, Pulmonary hypertensionAbstract
Background: Chronic kidney disease (CKD) is a challenging issue for health care providers and major burden for health care. Cardiovascular disease is a well-recognized and important source of mortality in a patient with chronic kidney disease. The aim of this study was to observe the frequency of pulmonary hypertension in chronic kidney disease patients at tertiary care hospital.
Methods: This cross sectional observational study was conducted in the Department of Medicine, Combined Military Hospital, Dhaka Cantonment, Bangladesh over a period of six months from 17th November 2019 to 16th May 2020.
Results: It was observed that majority, e.g., 28.0% patients belonged to age 41-50 years, mean age was found 41.4±9.7 years in Group-A and 42.1±8.5 years in Group-B. On evaluation of eGER, maximum patients (e.g., 61%) had <15 ml/min/1.73 m2, followed by 24.0% of patients had 15-29 ml/min/1.73 m2 and 15.0% case detected 30-59 ml/min/1.73 m2. Standard 2D, M mode echocardiographic was conducted in all patients. In this study, mPAP<25.0 mmHg was detected in 31 (62.0%) and 45 (90.0%) in group A and group B respectively. Overall prevalence of pulmonary hypertension was 24.0%. On comparison between groups, it is evident that frequency of pulmonary hypertension was predominant in patients with chronic kidney disease on maintenance haemodialysis than patients with chronic kidney disease without maintenance haemodialysis (38.0% vs. 10.0% respectively).
Conclusions: Pulmonary hypertension (PH) is common in patients with chronic kidney disease and is an independent predictor of mortality.
References
Allawi A, Alsodani M, Alqaisi A. Prevalence and Risk of Pulmonary Hypertension in Chronic Kidney Disease. Int J Sci Res. 2017;6(7):947-50.
Mukhtar KN, Mohkumuddin S, Mahmood SN. Frequency of pulmonary hypertension in hemodialysis patients. Pak J Med Sci. 2014;30(6):1319-22.
Lee B. Pulmonary hypertension in chronic kidney disease: what could change the fate? Kidney Res Clin Pract. 2016;35(1):63-4.
Lukela, J.K. Management of Chronic Kidney Disease. UMHS Chronic Kidney Disease Guideline. 2014: 1-14.
Medscape. Chronic Kidney Disease: Practice Essentials, Pathophysiology, Etiology. Available at: http://emedicine.medscape.com/article. Accessed 01 February 2016.
Hasan MJ, Kashem MA, Rahman MH, Quddhush R, Rahman M, Sharmeen A, et al. Prevalence of chronic kidney disease (CKD) and identification of associated risk factors among rural population by mass screening. CBMJ. 2012;1(1):20-6.
Dhondup T, Qian Q. Electrolyte and acid–base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif. 2017;43(1-3):179-88.
Thenappan T. Pulmonary hypertension in chronic kidney disease: a hemodynamic characterization. Pulm Circ. 2017;7(3):567-8.
Kawar B, Ellam T, Jackson C, Kiely DG. Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications. Am J Nephrol. 2013;37(3):281-90.
Rahman, T. Pattern of lipid profile in non-dialyzed patients with chronic kidney disease. FCPS Dissertation. 2012.
Feest TG, Mistry CD, Grimes DS, Mallick NP. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. Brit Med J. 1990;301(6757):897-900.
McGeown MG. Prevalence of advanced renal failure in Northern Ireland. BMJ. 1990;301(6757):900-3.
Rashid H. Management of end stage renal disease-Bangladesh Perspective. Open Urol Nephrol J. 2014;7(1):108-12.
Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014;125:229-40.
Pendreigh DM, Howitt LF, Macdougall AI, Robson JS, Heasman MA, Kennedy AC, et al. Survey of chronic renal failure in Scotland. Lancet. 1972;299(7745):304-7.
Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):43-54.
Badesch DB, Champion HC, Gomez Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 suppl):55-66.
Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohé C. Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: results of the PEPPER-Study. PLoS ONE. 2012;7(4).
Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, et al. Pulmonary hypertension in CKD. Am J Kidney Dis. 2013;61(4):612-22.
O'Leary JM, Assad TR, Xu M, Birdwell KA, Farber-Eger E, Wells QS, et al. Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ. 2017;7(3):674-83.
Tiengo A, Fadini GP, Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab. 2008;34(5):447-54.
Evans AM, Hardie DG, Peers C, Mahmoud A. Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing. Curr Opin Anaesthesiol. 2011;24(1):13-20.
Jabur A. A survey Report on Prevalence of Chronic kidney diseases and their treatment pattern in Dhaka City. Master of Pharmacy Research Report. Available at: http://dspace.ewubd.edu:8080/handle/ 123456789/1923. Accessed 01 July 2024.
